In September 2018, the Centers for Disease Control and Prevention (CDC) released a guideline on the Diagnosis and Management of Mild Traumatic Brain Injury Among Children. This guideline was developed in response to a growing number of children who are impacted by mild traumatic brain injury (mTBI), or concussion, and a lack of systematic guideline for diagnosing and treating pediatric mTBI. The Pediatric Mild Traumatic Brain Injury Guideline Workgroup produced this guideline which contains nineteen sets of evidence-based recommendations relating to the diagnosis, prognosis, and treatment of mTBI in children. Broadly, these recommendations address topics including neuroimaging, biomarkers, methods to monitor recovery, and management of symptoms including headache and sleep problems, among others.
The most common type of TBI is mTBI; symptoms include fatigue, headache, dizziness, seizures, and memory loss, among others. The Brain Injury Association of America emphasizes that pediatric TBI requires particular attention because brains develop throughout adolescence, making this population particularly susceptible to effects of TBI. Additionally, TBI in children is rather common – a CDC report indicates that there were 640,000 emergency room visits due to TBI in individuals aged 0-14 years in the U.S. in 2013.